Abiopharma

Belite Bio Announces Registered Direct Offering of $15 Million

RAPT Therapeutics Reports Second Quarter 2025 Financial Results

Addus HomeCare Names Heather Dixon President and Chief Operating Officer

Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025

Bausch Health Notification

New Form 8-K - PMV Pharmaceuticals, Inc. Filed: 2025-08-07 AccNo: 0000950170-25-104587 Size: 326 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Rallybio Reports Second Quarter 2025 Financial Results and Provides Business Updates

New Form 10-Q - PepGen Inc. Filed: 2025-08-07 AccNo: 0001193125-25-174979 Size: 8 MB

Daré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025

Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL

Replimune Reports Fiscal First Quarter 2026 Financial Results and Provides Corporate Update

Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service

New Form 8-K - Viatris Inc Filed: 2025-08-07 AccNo: 0001792044-25-000031 Size: 851 KB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 6-K - GSK plc Filed: 2025-08-07 AccNo: 0001654954-25-009167 Size: 8 MB

Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System